LU51306A1 - - Google Patents

Info

Publication number
LU51306A1
LU51306A1 LU51306A LU51306A LU51306A1 LU 51306 A1 LU51306 A1 LU 51306A1 LU 51306 A LU51306 A LU 51306A LU 51306 A LU51306 A LU 51306A LU 51306 A1 LU51306 A1 LU 51306A1
Authority
LU
Luxembourg
Application number
LU51306A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU51306A1 publication Critical patent/LU51306A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU51306A 1965-06-15 1966-06-13 LU51306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
LU51306A1 true LU51306A1 (es) 1966-08-16

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU51306A LU51306A1 (es) 1965-06-15 1966-06-13

Country Status (14)

Country Link
AT (1) AT272530B (es)
BE (1) BE682551A (es)
BR (1) BR6680359D0 (es)
CH (1) CH558362A (es)
DE (1) DE1620206A1 (es)
DK (1) DK115926B (es)
ES (1) ES327925A1 (es)
FI (1) FI49724C (es)
FR (1) FR6395M (es)
GB (1) GB1136214A (es)
LU (1) LU51306A1 (es)
NL (1) NL6608255A (es)
NO (1) NO119590B (es)
SE (1) SE325276B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) * 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2614223A1 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CN103450206A (zh) * 2008-07-30 2013-12-18 普渡制药公司 丁丙诺啡类似物
EP2342207B1 (en) 2008-09-30 2015-11-11 Mallinckrodt LLC Processes for the alkylation of norbuprenorphine with reduced impurity formation
WO2010121369A1 (en) 2009-04-24 2010-10-28 Brock University Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
MX352795B (es) 2011-12-12 2017-12-07 Lts Lohmann Therapie Systeme Ag Sistema de administracion transdermica que comprende buprenorfina.
EP2877155B1 (en) 2012-07-26 2020-10-28 Camurus AB Opioid formulations
EP2931729B1 (en) * 2012-12-07 2019-02-06 Purdue Pharma LP Buprenorphine analogs as opiod receptor modulators
GB2529789A (en) 2013-06-04 2016-03-02 Lohmann Therapie Syst Lts Transdermal Delivery system
CA3238849A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
FR6395M (es) 1968-10-21
SE325276B (es) 1970-06-29
BR6680359D0 (pt) 1973-12-26
AT272530B (de) 1969-07-10
DK115926B (da) 1969-11-24
NO119590B (es) 1970-06-08
FI49724B (es) 1975-06-02
DE1620206A1 (de) 1970-03-19
ES327925A1 (es) 1967-04-01
NL6608255A (es) 1966-12-16
GB1136214A (en) 1968-12-11
FI49724C (fi) 1975-09-10
BE682551A (es) 1966-11-14
CH558362A (de) 1975-01-31

Similar Documents

Publication Publication Date Title
FI49724B (es)
JPS4218106Y1 (es)
JPS4327996Y1 (es)
JPS433734Y1 (es)
JPS4519772Y1 (es)
BE660680A (es)
BE673904A (es)
BE658116A (es)
BE658161A (es)
BE659194A (es)
BE671633A (es)
BE661036A (es)
BE661304A (es)
BE662704A (es)
BE663744A (es)
BE663951A (es)
BE664335A (es)
BE664770A (es)
BE665466A (es)
NL6610910A (es)
LU49697A1 (es)
BE685406A (es)
BE684433A (es)
BE666227A (es)
BE689068A (es)